Published in PLoS One on May 19, 2010
Antibody-dependent cellular cytotoxicity is associated with control of pandemic H1N1 influenza virus infection of macaques. J Virol (2013) 1.53
T cell-mediated protection against lethal 2009 pandemic H1N1 influenza virus infection in a mouse model. J Virol (2010) 1.42
Two years after pandemic influenza A/2009/H1N1: what have we learned? Clin Microbiol Rev (2012) 1.31
Hallmarks of CD4 T cell immunity against influenza. J Intern Med (2011) 1.19
Response to 2009 pandemic influenza A (H1N1) vaccine in HIV-infected patients and the influence of prior seasonal influenza vaccination. PLoS One (2011) 1.15
Immunogenicity and cross-reactivity of 2009-2010 inactivated seasonal influenza vaccine in US adults and elderly. PLoS One (2011) 1.07
Profiling of humoral response to influenza A(H1N1)pdm09 infection and vaccination measured by a protein microarray in persons with and without history of seasonal vaccination. PLoS One (2013) 1.07
Pandemic influenza due to pH1N1/2009 virus: estimation of infection burden in Reunion Island through a prospective serosurvey, austral winter 2009. PLoS One (2011) 1.03
Cross-neutralizing antibodies to pandemic 2009 H1N1 and recent seasonal H1N1 influenza A strains influenced by a mutation in hemagglutinin subunit 2. PLoS Pathog (2011) 1.01
Animal models for influenza viruses: implications for universal vaccine development. Pathogens (2014) 0.99
Department of Defense influenza and other respiratory disease surveillance during the 2009 pandemic. BMC Public Health (2011) 0.96
Field effectiveness of pandemic and 2009-2010 seasonal vaccines against 2009-2010 A(H1N1) influenza: estimations from surveillance data in France. PLoS One (2011) 0.94
Effectiveness of seasonal influenza vaccines against influenza-associated illnesses among US military personnel in 2010-11: a case-control approach. PLoS One (2012) 0.93
Respiratory Infections in the U.S. Military: Recent Experience and Control. Clin Microbiol Rev (2015) 0.90
Outbreak of H3N2 influenza at a US military base in Djibouti during the H1N1 pandemic of 2009. PLoS One (2013) 0.90
Pre-existing cross-reactive antibodies to avian influenza H5N1 and 2009 pandemic H1N1 in US military personnel. Am J Trop Med Hyg (2013) 0.87
No association between 2008-09 influenza vaccine and influenza A(H1N1)pdm09 virus infection, Manitoba, Canada, 2009. Emerg Infect Dis (2012) 0.86
The human side of influenza. J Leukoc Biol (2012) 0.83
Options and obstacles for designing a universal influenza vaccine. Viruses (2014) 0.82
Demographic shift of influenza A(H1N1)pdm09 during and after pandemic, rural India. Emerg Infect Dis (2012) 0.81
Occurrence of AH1N1 viral infection and clinical features in symptomatic patients who received medical care during the 2009 influenza pandemic in Central Mexico. BMC Infect Dis (2012) 0.78
Partial protection against 2009 pandemic influenza A (H1N1) of seasonal influenza vaccination and related regional factors: Updated systematic review and meta-analyses. Hum Vaccin Immunother (2015) 0.77
Pandemic influenza A(H1N1)pdm09: risk of infection in primary healthcare workers. Br J Gen Pract (2013) 0.76
The Possible Impact of Vaccination for Seasonal Influenza on Emergence of Pandemic Influenza via Reassortment. PLoS One (2014) 0.76
Induction of neutralizing antibody response against four dengue viruses in mice by intramuscular electroporation of tetravalent DNA vaccines. PLoS One (2014) 0.76
Investigating the effect of AS03 adjuvant on the plasma cell repertoire following pH1N1 influenza vaccination. Sci Rep (2016) 0.75
Original Antigenic Sin Response to RNA Viruses and Antiviral Immunity. Immune Netw (2016) 0.75
Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med (2009) 16.13
Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med (2009) 15.02
Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. MMWR Morb Mortal Wkly Rep (2009) 9.94
Effectiveness of influenza vaccine in the community-dwelling elderly. N Engl J Med (2007) 7.29
Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells. PLoS One (2008) 6.98
Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus. Science (2010) 6.10
Use of influenza A (H1N1) 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep (2009) 6.09
Infection and death from influenza A H1N1 virus in Mexico: a retrospective analysis. Lancet (2009) 6.05
Prior H1N1 influenza infection and susceptibility of Cleveland Family Study participants during the H2N2 pandemic of 1957: an experiment of nature. J Infect Dis (2005) 5.19
Field evaluation of vaccine efficacy. Bull World Health Organ (1985) 4.95
Outbreak of 2009 pandemic influenza A (H1N1) at a New York City school. N Engl J Med (2009) 4.60
Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population. Proc Natl Acad Sci U S A (2009) 4.47
T cell responses are better correlates of vaccine protection in the elderly. J Immunol (2006) 4.38
Partial protection of seasonal trivalent inactivated vaccine against novel pandemic influenza A/H1N1 2009: case-control study in Mexico City. BMJ (2009) 4.31
Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals. J Clin Invest (2008) 4.30
Evidence of bias in estimates of influenza vaccine effectiveness in seniors. Int J Epidemiol (2005) 4.04
Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada. PLoS Med (2010) 3.85
Comparative efficacy of inactivated and live attenuated influenza vaccines. N Engl J Med (2009) 3.49
Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors. Nature (2008) 3.47
Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness. Int J Epidemiol (2007) 3.33
Interim analysis of pandemic influenza (H1N1) 2009 in Australia: surveillance trends, age of infection and effectiveness of seasonal vaccination. Euro Surveill (2009) 3.30
2009 influenza A(H1N1) seroconversion rates and risk factors among distinct adult cohorts in Singapore. JAMA (2010) 3.05
The Defense Medical Surveillance System and the Department of Defense serum repository: glimpses of the future of public health surveillance. Am J Public Health (2002) 2.92
Respiratory diseases among U.S. military personnel: countering emerging threats. Emerg Infect Dis (1999) 2.61
Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007. J Infect Dis (2009) 2.59
Notes from the field: outbreak of 2009 pandemic influenza A (H1N1) virus at a large public university in Delaware, April-May 2009. Clin Infect Dis (2009) 2.56
The role of the antibody response in influenza virus infection. Curr Top Microbiol Immunol (2001) 2.52
Swine influenza a outbreak, Fort Dix, New Jersey, 1976. Emerg Infect Dis (2006) 2.40
Half- vs full-dose trivalent inactivated influenza vaccine (2004-2005): age, dose, and sex effects on immune responses. Arch Intern Med (2008) 2.24
Cross-recognition of avian H5N1 influenza virus by human cytotoxic T-lymphocyte populations directed to human influenza A virus. J Virol (2008) 2.24
Healthy human subjects have CD4+ T cells directed against H5N1 influenza virus. J Immunol (2008) 2.21
Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens. Arch Intern Med (1998) 2.03
Cross-subtype immunity against avian influenza in persons recently vaccinated for influenza. Emerg Infect Dis (2008) 1.98
Recognition of homo- and heterosubtypic variants of influenza A viruses by human CD8+ T lymphocytes. J Immunol (2004) 1.87
Preexisting immunity to pandemic (H1N1) 2009. Emerg Infect Dis (2009) 1.85
Live attenuated or inactivated influenza vaccines and medical encounters for respiratory illnesses among US military personnel. JAMA (2009) 1.74
New evidence of risk factors for community-acquired pneumonia: a population-based study. Eur Respir J (2008) 1.70
Comparison of the trivalent live attenuated vs. inactivated influenza vaccines among U.S. military service members. Vaccine (2009) 1.70
Immunization to protect the US Armed Forces: heritage, current practice, and prospects. Epidemiol Rev (2006) 1.65
Prevention of symptomatic seasonal influenza in 2005-2006 by inactivated and live attenuated vaccines. J Infect Dis (2008) 1.58
Effectiveness of 2008-09 trivalent influenza vaccine against 2009 pandemic influenza A (H1N1) - United States, May-June 2009. MMWR Morb Mortal Wkly Rep (2009) 1.58
Rapid decline of influenza vaccine-induced antibody in the elderly: is it real, or is it relevant? J Infect Dis (2008) 1.57
Influenza vaccine effectiveness in preventing hospitalization for pneumonia in the elderly. Am J Epidemiol (1992) 1.47
Cigarette smoke worsens lung inflammation and impairs resolution of influenza infection in mice. Respir Res (2008) 1.46
Neutralizing anti-influenza virus monoclonal antibodies: therapeutics and tools for discovery. Int Rev Immunol (2009) 1.13
Effect of yearly vaccinations with live, attenuated, cold-adapted, trivalent, intranasal influenza vaccines on antibody responses in children. Pediatr Infect Dis J (2003) 0.97
Comparative immunogenicities of frozen and refrigerated formulations of live attenuated influenza vaccine in healthy subjects. Antimicrob Agents Chemother (2007) 0.95
Swine flu pandemic. What's old is new: 1918 virus matches 2009 H1N1 strain. Science (2010) 0.89
Pandemic (H1N1) 2009 risk for nurses after trivalent vaccination. Emerg Infect Dis (2010) 0.86
Heterosubtypic T-cell responses against avian influenza H5 haemagglutinin are frequently detected in individuals vaccinated against or previously infected with human subtypes of influenza. Influenza Other Respir Viruses (2008) 0.86
De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases. Arthritis Rheum (2002) 4.98
Association of herpes simplex virus type 2 infection and syphilis with human immunodeficiency virus infection among men who have sex with men in Peru. J Infect Dis (2006) 2.83
HIV-1, sexually transmitted infections, and sexual behavior trends among men who have sex with men in Lima, Peru. J Acquir Immune Defic Syndr (2007) 2.71
Arboviral etiologies of acute febrile illnesses in Western South America, 2000-2007. PLoS Negl Trop Dis (2010) 2.60
Abrupt emergence of diverse species B adenoviruses at US military recruit training centers. J Infect Dis (2007) 2.56
Effect of dengue-1 antibodies on American dengue-2 viral infection and dengue haemorrhagic fever. Lancet (2002) 2.56
Syndromic surveillance: adapting innovations to developing settings. PLoS Med (2008) 2.38
Global surveillance of emerging Influenza virus genotypes by mass spectrometry. PLoS One (2007) 2.29
Fifteen-year study of the changing epidemiology of methicillin-resistant Staphylococcus aureus. Am J Med (2006) 2.26
Epidemiology of dengue virus in Iquitos, Peru 1999 to 2005: interepidemic and epidemic patterns of transmission. PLoS Negl Trop Dis (2010) 2.17
Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals. Cancer (2005) 2.09
Department of Defense Global Laboratory-Based Influenza Surveillance: 1998-2005. Am J Prev Med (2009) 1.87
Prevalences, genotypes, and risk factors for HIV transmission in South America. J Acquir Immune Defic Syndr (2005) 1.82
Risk factors for community-associated methicillin-resistant Staphylococcus aureus infections in an outbreak of disease among military trainees in San Diego, California, in 2002. J Clin Microbiol (2004) 1.80
The US capitol bioterrorism anthrax exposures: clinical epidemiological and immunological characteristics. J Infect Dis (2006) 1.70
Using a resequencing microarray as a multiple respiratory pathogen detection assay. J Clin Microbiol (2006) 1.64
PCR analysis of egyptian respiratory adenovirus isolates, including identification of species, serotypes, and coinfections. J Clin Microbiol (2005) 1.63
Genotype prevalence and risk factors for severe clinical adenovirus infection, United States 2004-2006. Clin Infect Dis (2007) 1.63
Pseudoporphyria as a result of voriconazole use: a case report. Int J Dermatol (2004) 1.61
The importance of militaries from developing countries in global infectious disease surveillance. Bull World Health Organ (2007) 1.60
Challenges in the implementation of an electronic surveillance system in a resource-limited setting: Alerta, in Peru. BMC Proc (2008) 1.53
Etiology of acute undifferentiated febrile illness in the Amazon basin of Ecuador. Am J Trop Med Hyg (2009) 1.52
Molecular Epidemiology of HIV Type 1 in Ecuador, Peru, Bolivia, Uruguay, and Argentina. AIDS Res Hum Retroviruses (2002) 1.50
Exploration of the effectiveness of social distancing on respiratory pathogen transmission implicates environmental contributions. J Infect Dis (2008) 1.50
Outbreak of a West African recombinant of HIV-1 in Tashkent, Uzbekistan. J Acquir Immune Defic Syndr (2005) 1.49
Trauma-related infections in battlefield casualties from Iraq. Ann Surg (2007) 1.49
Vaccination and risk of type 1 diabetes mellitus in active component U.S. Military, 2002-2008. Vaccine (2011) 1.47
Endemic Venezuelan equine encephalitis in northern Peru. Emerg Infect Dis (2004) 1.47
Active tuberculosis and recent overseas deployment in the U.S. military. Am J Prev Med (2010) 1.46
Large epidemic of adenovirus type 4 infection among military trainees: epidemiological, clinical, and laboratory studies. Clin Infect Dis (2002) 1.45
Impact of two interventions on timeliness and data quality of an electronic disease surveillance system in a resource limited setting (Peru): a prospective evaluation. BMC Med Inform Decis Mak (2009) 1.45
Late urinary tract infection after renal transplantation in the United States. Am J Kidney Dis (2004) 1.45
Cross-serotype neutralization of dengue virus in Aotus nancymae monkeys. J Infect Dis (2005) 1.43
Higher concentration of HIV RNA in rectal mucosa secretions than in blood and seminal plasma, among men who have sex with men, independent of antiretroviral therapy. J Infect Dis (2004) 1.35
Exchange transfusion as an adjunct therapy in severe Plasmodium falciparum malaria: a meta-analysis. Clin Infect Dis (2002) 1.35
Genetic relationships among Mayaro and Una viruses suggest distinct patterns of transmission. Am J Trop Med Hyg (2006) 1.33
Spatial dimensions of dengue virus transmission across interepidemic and epidemic periods in Iquitos, Peru (1999-2003). PLoS Negl Trop Dis (2012) 1.32
Broad spectrum respiratory pathogen analysis of throat swabs from military recruits reveals interference between rhinoviruses and adenoviruses. Microb Ecol (2010) 1.31
Preparing military installations for pandemic influenza through tabletop exercises. Mil Med (2010) 1.25
A multiplex PCR for detection of Mycoplasma pneumoniae, Chlamydophila pneumoniae, Legionella pneumophila, and Bordetella pertussis in clinical specimens. Mol Cell Probes (2005) 1.24
Evaluation of brucellosis by PCR and persistence after treatment in patients returning to the hospital for follow-up. Am J Trop Med Hyg (2007) 1.22
Climate teleconnections and recent patterns of human and animal disease outbreaks. PLoS Negl Trop Dis (2012) 1.20
Linking HIV and antiretroviral drug resistance surveillance in Peru: a model for a third-generation HIV sentinel surveillance. J Acquir Immune Defic Syndr (2006) 1.18
Outbreak of cyclosporiasis at a naval base in Lima, Peru. Am J Trop Med Hyg (2006) 1.17
Dengue virus infections in a cohort of schoolchildren from Maracay, Venezuela: a 2-year prospective study. Vector Borne Zoonotic Dis (2008) 1.16
Two HIV-1 epidemics in Argentina: different genetic subtypes associated with different risk groups. J Acquir Immune Defic Syndr (2002) 1.16
The Global Emerging Infection Surveillance and Response System (GEIS), a U.S. government tool for improved global biosurveillance: a review of 2009. BMC Public Health (2011) 1.15
Molecular epidemiology of adenovirus type 4 infections in US military recruits in the postvaccination era (1997-2003). J Infect Dis (2007) 1.14
SAGES: a suite of freely-available software tools for electronic disease surveillance in resource-limited settings. PLoS One (2011) 1.13
Comparison of culture techniques at different stages of brucellosis. Am J Trop Med Hyg (2009) 1.13
An outbreak of Plasmodium falciparum malaria in U.S. Marines deployed to Liberia. Am J Trop Med Hyg (2010) 1.12
Molecular analysis of adenovirus isolates from vaccinated and unvaccinated young adults. J Clin Microbiol (2004) 1.11
Experience of a global laboratory network in responding to infectious disease epidemics. Lancet Infect Dis (2006) 1.10
Rapid detection of adenovirus in throat swab specimens by PCR during respiratory disease outbreaks among military recruits. J Clin Microbiol (2003) 1.09
Sexual transmission of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus type 1 infections among male transvestite comercial sex workers in Montevideo, Uruguay. Am J Trop Med Hyg (2003) 1.09
Molecular epidemiology of HIV Type 1 in Ukraine: birthplace of an epidemic. AIDS Res Hum Retroviruses (2006) 1.08
Prevalence of lifetime abortion and methods of contraception among female sex workers in Bogota, Colombia. Contraception (2008) 1.07
Influenza and respiratory disease surveillance: the US military's global laboratory-based network. Influenza Other Respir Viruses (2010) 1.07
Randomized, double-blind, phase III, pivotal field trial of the comparative immunogenicity, safety, and tolerability of two yellow fever 17D vaccines (Arilvax and YF-VAX) in healthy infants and children in Peru. Am J Trop Med Hyg (2005) 1.06
Viral agents responsible for febrile respiratory illnesses among military recruits training in tropical Singapore. J Clin Virol (2010) 1.06
First case of HIV Type 1 subtype F among men who have sex with men in Colombia. AIDS Res Hum Retroviruses (2006) 1.04
Rapid diagnostic test for Plasmodium falciparum in 32 Marines medically evacuated from Liberia with a febrile illness. Ann Intern Med (2005) 1.03
Statistical analyses in disease surveillance systems. BMC Proc (2008) 1.02
Epidemiology. Outbreak investigation and response training. Science (2007) 1.02
Rapid type-specific diagnosis of adenovirus type 4 infection using a hexon-based quantitative fluorogenic PCR. Diagn Microbiol Infect Dis (2002) 1.02
U.S. Government engagement in support of global disease surveillance. BMC Public Health (2010) 1.02
Capacity-building efforts by the AFHSC-GEIS program. BMC Public Health (2011) 1.02
Utilization of contraception and abortion and its relationship to HIV infection among female sex workers in Tashkent, Uzbekistan. Contraception (2006) 1.00
Family cluster of Mayaro fever, Venezuela. Emerg Infect Dis (2004) 1.00
Pneumonia outbreak associated with group a Streptococcus species at a military training facility. Clin Infect Dis (2005) 0.98
Genetic characterization of HIV-1 strains circulating in Kazakhstan. J Acquir Immune Defic Syndr (2007) 0.97
Application of broad-spectrum, sequence-based pathogen identification in an urban population. PLoS One (2007) 0.97
Global health. N Engl J Med (2013) 0.97
Antimicrobial susceptibility and serotype distribution of Streptococcus pneumoniae causing meningitis in Egypt, 1998-2003. J Antimicrob Chemother (2005) 0.96
Department of Defense influenza and other respiratory disease surveillance during the 2009 pandemic. BMC Public Health (2011) 0.96
A growing global network's role in outbreak response: AFHSC-GEIS 2008-2009. BMC Public Health (2011) 0.96
Genetic forms of HIV Type 1 in the former Soviet Union dominate the epidemic in Azerbaijan. AIDS Res Hum Retroviruses (2006) 0.95
Selected nonvaccine interventions to prevent infectious acute respiratory disease. Am J Prev Med (2005) 0.95
Prevalence and correlates of condom use and HIV testing among female sex workers in Tashkent, Uzbekistan: implications for HIV transmission. AIDS Behav (2007) 0.95
Rapid detection and molecular serotyping of adenovirus by use of PCR followed by electrospray ionization mass spectrometry. J Clin Microbiol (2007) 0.94
Training initiatives within the AFHSC-Global Emerging Infections Surveillance and Response System: support for IHR (2005). BMC Public Health (2011) 0.94
Influenza vaccine effectiveness among US military basic trainees, 2005-06 season. Emerg Infect Dis (2007) 0.93